Show item record

dc.contributor.authorBosoi, Cristina R.
dc.contributor.authorRose, Christopher
dc.date.accessioned2014-03-24T19:42:58Z
dc.date.available2014-03-24T19:42:58Z
dc.date.issued2013
dc.identifier.urihttp://hdl.handle.net/1866/10395
dc.subjectOxidative stressfr
dc.subjectLiver diseasefr
dc.subjectAmmoniafr
dc.subjectHepatic encephalopathyfr
dc.subjectStress oxydatiffr
dc.subjectMaladies du foiefr
dc.subjectAmmoniacfr
dc.subjectEncéphalopathie hépatiquefr
dc.titleOxidative stress: a systemic factor implicated in the pathogenesis of hepatic encephalopathy
dc.typeArticlefr
dc.contributor.affiliationUniversité de Montréal. Faculté de médecinefr
dc.contributor.affiliationUniversité de Montréal. Faculté de médecine. Centre de recherche du CHUMfr
dc.identifier.doi10.1007/s11011-012-9351-5
dcterms.abstractAlthough ammonia is considered the main factor involved in the pathogenesis of hepatic encephalopathy (HE), it correlates well with the severity of HE in acute liver failure, but not in chronic liver disease. Oxidative stress is another factor believed to play a role in the pathogenesis of this syndrome; it represents an imbalance between the production and neutralization of reactive oxygen species, which leads to cellular dysfunction. In the setting of liver disease, oxidative stress represents a systemic phenomenon induced by several mechanisms: decreased antioxidant synthesis, increased systemic release of oxidant enzymes, generation of reactive oxygen species, and impaired neutrophil function. High ammonia concentrations induce cerebral oxidative stress, thus contributing to severe hepatic encephalopathy, as observed in acute liver failure. In chronic liver disease, significantly lower degrees of hyperammonemia (<500 μM) do not induce cerebral nor systemic oxidative stress. Data from both animal and human studies sustain that there is a synergistic effect between systemic oxidative stress, and ammonia that is implicated in the pathogenesis of hepatic encephalopathy.fr
dcterms.languageengfr
UdeM.VersionRioxxVersion acceptée / Accepted Manuscript
oaire.citationTitleMetabolic brain disease
oaire.citationVolume28
oaire.citationIssue2
oaire.citationStartPage175
oaire.citationEndPage178


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show item record

This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.